Dispensing Solution, Northwind Pharmaceuticals

Dispensing Regulations: It’s Better than you Think

Dispensing-Regulations-Its-Better-than-you-Think.UPDATED: June 2, 2018

When it comes to in-house dispensing, it may surprise you to know that in many states, the license to dispense is a part of the physician’s medical license. While regulations vary from state to state, you may find that adding dispensing to your clinic is easier than you thought.

For example, dispensing in Indiana is allowed under the Indiana Legend Drug Act, IC 16-42-19. In.gov details the act which “allows specific Indiana practitioners to dispense legend drugs directly to their patients in the course of their professional practice.”

Who can dispense?

What can be dispensed?

According to in.gov, “As long as the labeling requirements and reporting requirements (if dispensing controls) are met, an Indiana practitioner may dispense any legend drug they are allowed to prescribe under their:

  • Indiana professional license;
  • CSR and DEA registrations (if dispensing controlled substances); and/or
  • Collaborative practice agreement (if this is required to prescribe)”

Are there any label requirements?

Any dispensed medications must be labeled with:

  • The directions for use of the drug.
  • The name and address of the practitioner.
  • The name of the patient.
  • If the drug is prescribed for an animal, a statement of the species of the animal.

Not every state handles in-office dispensing the same way. Contact one of our account managers to help identify the requirements for your state.

Adding physician dispensing to your clinic is a great way to bring in supplemental revenue as well as provide a convenient service to your patients. With Northwind Pharmaceuticals, it is also easier than you may have imagined. Our solutions make adding and implementing in-house dispensing simple.Contact us today to see how our solutions can work for you.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading